The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Immune‐mediated necrotizing myopathy associated with statins
Abstract
We report patients from two neuromuscular centers who were evaluated between the years 2000 and 2008 and met the following criteria: (1) proximal muscle weakness occurring during or after treatment with statins; (2) elevated serum creatine kinase (CK); (3) persistence of weakness and elevated CK despite discontinuation of the statin; (4) improvement with immunosuppressive agents; and (5) muscle biopsy showing necrotizing myopathy without significant inflammation. Twenty‐five patients fulfilled our inclusion criteria. Twenty‐four patients required multiple immunosuppressive agents. Fifteen patients relapsed after being tapered off immunosuppressive therapy. Exposure to statins prior to onset was significantly higher in patients with necrotizing myopathy (82%) as compared to those with dermatomyositis (18%), polymyositis (24%), and inclusion‐body myositis (38%) seen in the same time period. The lack of improvement following discontinuation of statins, the need for immunosuppressive therapy, and frequent relapse when treatment was tapered suggest an immune‐mediated etiology for this rare, statin‐associated necrotizing myopathy. Muscle Nerve, 2010
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Thompson, P. D., Clarkson, P., & Karas, R. H. (2003) · JAMA · doi:10.1001/jama.289.13.1681 · Cited by 1,463
Polymyositis and dermatomyositis
Dalakas, M. C., & Hohlfeld, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14368-1 · Cited by 1,416
Hoogendijk, J. E., Amato, A. A., Lecky, B. R., Choy, E. H., Lundberg, I. E., Rose, M. R., Vencovsky, J., de Visser, M., & Hughes, R. A. (2004) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.02.006 · Cited by 950
Self-citationInclusion body myositis and myopathies
Griggs, R. C., Askanas, V., DiMauro, S., Engel, A., Karpati, G., Mendell, J. R., & Rowland, L. P. (1995) · Annals of Neurology · doi:10.1002/ana.410380504 · Cited by 837
Statin-associated myopathy with normal creatine kinase levels
Phillips, P. S., Haas, R. H., Bannykh, S., Hathaway, S., Gray, N. L., Kimura, B. J., Vladutiu, G. D., England, J. D. F., & and the Scripps Mercy Clinical Research Center* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00009 · Cited by 565
Myopathy and Rhabdomyolysis Associated With Lovastatin-Gemfibrozil Combination Therapy
Pierce, L. R. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450010075034 · Cited by 428
Progressive myopathy with up-regulation of MHC-I associated with statin therapy
Needham, M., Fabian, V., Knezevic, W., Panegyres, P., Zilko, P., & Mastaglia, F. L. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.10.007 · Cited by 250
Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review
Noël, B. (2006) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2006.01838.x · Cited by 153
Autoimmune Hepatitis Triggered by Statins
Alla, V., Abraham, J. P., Siddiqui, J., Raina, D., Wu, G. Y., Chalasani, N., & Bonkovsky, H. L. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200609000-00018 · Cited by 137
Pravastatin-Associated Inflammatory Myopathy
Schalke, B. C. G., Schmidt, B. L., Toyka, K. V., & Hartung, H. ‐. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208273270919 · Cited by 104
Dermatomyositis‐like syndrome and HMG‐CoA reductase inhibitor (statin) intake
Vasconcelos, O. M., & Campbell, W. W. (2004) · Muscle & Nerve · doi:10.1002/mus.20127 · Cited by 71
Statin-Associated Myasthenia Gravis: Report of 4 Cases and Review of the Literature
Purvin, V. A., Kawasaki, A., Smith, K. H., & Kesler, A. (2006) · Medicine · doi:10.1097/01.md.0000209337.59874.aa · Cited by 71
Simvastatin-associated Dermatomyositis
Khattak, F., Morris, I. M., & Branford, W. A. (1994) · Lara D. Veeken · doi:10.1093/rheumatology/33.2.199 · Cited by 68
Polymyositis associated with simvastatin
Giordano, N. G., Senesi, M., Mattii, G., Battisti, E., Villanova, M., & Gennari, C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61628-5 · Cited by 66
Atorvastatin-induced dermatomyositis
Noël, B., Cerottini, J., & Panizzon, R. G. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00711-2 · Cited by 66
Rhabdomyolysis induced by simvastatin and ketoconazole treatment.
Gilad, R., & Lampl, Y. (1999) · PubMed · Cited by 58
Polymyosites induites ou associées aux traitements hypolipémiants ?
Fauchais, A. L., Ba, J. I., Maurage, P., Kyndt, X., Bataille, D., HACHULLA, E., Parent, D., Queyrel, V., Lambert, M., Pasturel, U. M., et al. (2003) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2003.10.013 · Cited by 58
Dermatomyositis with lung involvement in a patient treated with simvastatin
Hill, C. T. G., Zeitz, C. J., & Kirkham, B. W. (1995) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1995.tb02870.x · Cited by 53
Lovastatin-associated dermatomyositis
Rodríguez-García, J. L., & Commino, M. S. (1996) · Postgraduate Medical Journal · doi:10.1136/pgmj.72.853.694 · Cited by 40
Rudski, L., Rabinovitch, M. A., & Danoff, D. S. (1998) · Medicine · doi:10.1097/00005792-199811000-00002 · Cited by 36
HMG-CoA Reductase Inhibitor Myopathy
Meriggioli, M. N., Barboi, A. C., Rowin, J., & Cochran, E. J. (2001) · Journal of Clinical Neuromuscular Disease · doi:10.1097/00131402-200103000-00003 · Cited by 28
Cited by
Statin-Associated Side Effects
Thompson, P. D., Panza, G., Zaleski, A., & Taylor, B. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.071 · Cited by 739
Mammen, A. L., Chung, T., Christopher-Stine, L., Rosen, P., Rosen, A., Doering, K. R., & Casciola-Rosen, L. A. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30156 · Cited by 699
224th ENMC International Workshop:
Allenbach, Y., Mammen, A. L., Benveniste, O., Stenzel, W., Allenbach, Y., Amato, A., Aussey, A., Benveniste, O., De Bleecker, J., de Groot, I., et al. (2018) · Neuromuscular Disorders · doi:10.1016/j.nmd.2017.09.016 · Cited by 582
Self-citationChristopher‐Stine, L., Casciola‐Rosen, L. A., Hong, G., Chung, T., Corse, A. M., & Mammen, A. L. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27572 · Cited by 512
Statin-Associated Autoimmune Myopathy
Mammen, A. L. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1515161 · Cited by 366
Metadata
- Authors
- Grable‐Esposito, P., Katzberg, H. D., Greenberg, S. A., Srinivasan, J., Katz, J., & Amato, A. A.
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2009-10-07
- Volume
- 41
- Issue
- 2
- Pages
- 185-190
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W2163226208
- Cited by
- 340
- References
- 22
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.